Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accounts Payables (2016 - 2025)

Rockwell Medical's Accounts Payables history spans 16 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 30.32% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 30.32%, while the annual FY2025 figure was $2.0 million, 30.32% down from the prior year.
  • Accounts Payables reached $2.0 million in Q4 2025 per RMTI's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $5.9 million in Q2 2023 to a low of $1.5 million in Q2 2025.
  • Average Accounts Payables over 5 years is $3.6 million, with a median of $3.5 million recorded in 2021.
  • Peak YoY movement for Accounts Payables: surged 101.46% in 2023, then crashed 60.87% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $3.7 million in 2021, then grew by 8.4% to $4.1 million in 2022, then grew by 11.42% to $4.5 million in 2023, then plummeted by 36.47% to $2.9 million in 2024, then plummeted by 30.32% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Accounts Payables are $2.0 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).